Anjali Mahto
Research Subjects
Anjali Mahto has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Dominique du Crest
SkinAid SAS Paris France
3 shared publications - Monisha Madhumita
Department of Dermatology, Saveetha Medical College, Chennai, Tamil Nadu, India
3 shared publications - Adewole S. Adamson
Department of Internal Medicine, Dell Medical School, Austin, Texas; Division of Dermatology, Dell Medical School, University of Texas, Austin, Texas
2 shared publications - Art Papier
Department of Dermatology, University of Rochester College of Medicine, Rochester, NY, United States
2 shared publications - Charbel Skayem
Faculty of Medicine Sorbonne Université Paris France
2 shared publications - Esther E. Freeman
Department of Dermatology, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Elsevier in JID Innovations
What people with psoriasis talk about online: Insights from a digital ethnography of lived experience
- 3 November 2026
- Published by Elsevier in JID Innovations
Open AccessWhat people with psoriasis talk about online: Insights from a digital ethnography of lived experience
- Open Access
- 28 September 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (10)
Hydrolyzed Collagen for Skin Aging Meta‐Analyses Are Unreliable
Background: Scientific evidence for oral collagen supplementation in skin aging remains controversial and limited, with various trials finding conflicting results on skin parameters such as reduction in wrinkle depth, increases in hydration and elasticity. These parameters are measured with a variety of methodologies, and recent meta‐analyses have attempted to synthesize existent evidence to ascertain potential benefits. The question of whether these measures are readily comparable, however, has led to concerns about the internal validity and interpretability of these efforts. Aims: To investigate major existing meta‐analyses on oral collagen supplementation and perform a technical re‐analysis of both methodology and reported results, as well as a full meta‐regression of constituent collagen studies accounting for dose effects to ascertain evidence quality. Methods: Data investigation and evidence appraisal of the methodology of existing meta‐analyses of collagen supplementation and implementation of meta‐regression accounting for cumulative dose effects. Results: In both identified meta‐analyses, we find inaccurate reporting of data from primary studies and inappropriate combinations of measures likely to give rise to spurious results. Meta‐regression of collagen studies accounting for dose variations in primary studies found no evidence of benefit from collagen supplementation. Conclusion: In sharp contrast to the reported results from prior meta‐analysis, this investigation does not find evidence of benefit for supplementation from existing collagen studies. Evidence synthesis for collagen studies needs a stronger methodological underpinning if results are to be clinically relevant.
- 28 September 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (10)
Open AccessHydrolyzed Collagen for Skin Aging Meta‐Analyses Are Unreliable
Background: Scientific evidence for oral collagen supplementation in skin aging remains controversial and limited, with various trials finding conflicting results on skin parameters such as reduction in wrinkle depth, increases in hydration and elasticity. These parameters are measured with a variety of methodologies, and recent meta‐analyses have attempted to synthesize existent evidence to ascertain potential benefits. The question of whether these measures are readily comparable, however, has led to concerns about the internal validity and interpretability of these efforts. Aims: To investigate major existing meta‐analyses on oral collagen supplementation and perform a technical re‐analysis of both methodology and reported results, as well as a full meta‐regression of constituent collagen studies accounting for dose effects to ascertain evidence quality. Methods: Data investigation and evidence appraisal of the methodology of existing meta‐analyses of collagen supplementation and implementation of meta‐regression accounting for cumulative dose effects. Results: In both identified meta‐analyses, we find inaccurate reporting of data from primary studies and inappropriate combinations of measures likely to give rise to spurious results. Meta‐regression of collagen studies accounting for dose variations in primary studies found no evidence of benefit from collagen supplementation. Conclusion: In sharp contrast to the reported results from prior meta‐analysis, this investigation does not find evidence of benefit for supplementation from existing collagen studies. Evidence synthesis for collagen studies needs a stronger methodological underpinning if results are to be clinically relevant.
- Top Cited PapersOpen Access
- 20 February 2026
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e79044
AI and Digital Tools in Dermatology: Addressing Access and Misinformation
Digital dermatology, which is defined as the use of digital technologies that leverage individual- and population-level skin data to improve the diagnosis, treatment, and prevention of skin diseases, has emerged as a critical frontier for bridging persistent gaps in dermatologic care. This transformation holds particular promise for addressing long-standing inequities linked to geography, income, and skin type. According to the Global Burden of Disease 2023 study, skin and subcutaneous diseases remain among the most prevalent global health conditions, contributing substantially to disability-adjusted life years. Digital tools (including teledermatology, artificial intelligence [AI], and large language models) offer new ways to extend diagnosis, education, and patient empowerment to historically underserved populations. However, these same innovations risk amplifying disparities if they are not designed and deployed intentionally. Algorithmic bias, uneven digital access, and the absence of culturally responsive models can undermine progress. In this conceptual and narrative review, we draw on expert dialogues and illustrative literature, including multistakeholder exchanges at the Skin and Digital Summit (2023-2025 ) and related global forums, to examine how digital dermatology can promote equitable skin health. We focus on 3 interlinked priorities: expanding access through scalable digital platforms, ensuring AI fairness via comprehensive and diverse datasets, and countering dermatological misinformation. Central to the latter is a bot concept described here as a dynamic cycle that analyzes scientific literature; ranks evidence; translates complex research into clear language; and delivers trustworthy, personalized guidance to both consumers and clinicians. By embedding expert oversight and evidence prioritization, such tools can ensure that accurate, actionable information reaches users at the speed and scale of the internet. Drawing on case studies (including lessons from the World Health Organization’s AI skin health app) and insights from the Skin and Digital Summit , we highlight both the transformative potential and the ethical complexities of these digital solutions. To navigate this evolving landscape, we propose the concept of radical dermatology , which confronts the reality that big tech is reshaping skin health whether we like it or not and insists that dermatologists and stakeholders lead the transformation through bold collaboration and unwavering clinical relevance.
- 20 February 2026
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e79044
Top Cited PapersOpen AccessAI and Digital Tools in Dermatology: Addressing Access and Misinformation
Digital dermatology, which is defined as the use of digital technologies that leverage individual- and population-level skin data to improve the diagnosis, treatment, and prevention of skin diseases, has emerged as a critical frontier for bridging persistent gaps in dermatologic care. This transformation holds particular promise for addressing long-standing inequities linked to geography, income, and skin type. According to the Global Burden of Disease 2023 study, skin and subcutaneous diseases remain among the most prevalent global health conditions, contributing substantially to disability-adjusted life years. Digital tools (including teledermatology, artificial intelligence [AI], and large language models) offer new ways to extend diagnosis, education, and patient empowerment to historically underserved populations. However, these same innovations risk amplifying disparities if they are not designed and deployed intentionally. Algorithmic bias, uneven digital access, and the absence of culturally responsive models can undermine progress. In this conceptual and narrative review, we draw on expert dialogues and illustrative literature, including multistakeholder exchanges at the Skin and Digital Summit (2023-2025 ) and related global forums, to examine how digital dermatology can promote equitable skin health. We focus on 3 interlinked priorities: expanding access through scalable digital platforms, ensuring AI fairness via comprehensive and diverse datasets, and countering dermatological misinformation. Central to the latter is a bot concept described here as a dynamic cycle that analyzes scientific literature; ranks evidence; translates complex research into clear language; and delivers trustworthy, personalized guidance to both consumers and clinicians. By embedding expert oversight and evidence prioritization, such tools can ensure that accurate, actionable information reaches users at the speed and scale of the internet. Drawing on case studies (including lessons from the World Health Organization’s AI skin health app) and insights from the Skin and Digital Summit , we highlight both the transformative potential and the ethical complexities of these digital solutions. To navigate this evolving landscape, we propose the concept of radical dermatology , which confronts the reality that big tech is reshaping skin health whether we like it or not and insists that dermatologists and stakeholders lead the transformation through bold collaboration and unwavering clinical relevance.
- Open Access
- 26 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
AI and Digital Tools in Dermatology: Addressing Access and Misinformation in 2025 (Preprint)
UNSTRUCTURED Digital dermatology is transforming access to skin care by addressing long-standing inequities related to geography, income, and skin type. As many as 70% of individuals with skin conditions do not receive professional care, creating an opportunity for digital tools - ranging from teledermatology and AI to large language models - to bridge gaps in diagnosis, education, and patient empowerment. However, these innovations could worsen existing disparities if not designed intentionally, due to algorithmic bias, unequal digital access, and a lack of culturally responsive models. This paper examines digital dermatology's potential to promote equitable care by focusing on three critical areas: broadening access via digital platforms, ensuring AI fairness through comprehensive datasets, and combating dermatological misinformation using expert-led, AI-powered communication strategies, including a conceptual chatbot that synthesizes and prioritizes dermatologic science for practical use. Drawing on global case studies and insights from the WHO’s AI skin health app and the Skin and Digital Summit, we underscore both the transformative potential and ethical complexities of deploying digital solutions. We advocate for a Radical Dermatology framework that integrates technological advances with community-centered care, equitable data practices, and collaborative design. This vision calls for dermatologists to take the lead, combining scientific rigor with digital innovation to cultivate a more inclusive, intelligent, and trustworthy skin health ecosystem.
- 26 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAI and Digital Tools in Dermatology: Addressing Access and Misinformation in 2025 (Preprint)
UNSTRUCTURED Digital dermatology is transforming access to skin care by addressing long-standing inequities related to geography, income, and skin type. As many as 70% of individuals with skin conditions do not receive professional care, creating an opportunity for digital tools - ranging from teledermatology and AI to large language models - to bridge gaps in diagnosis, education, and patient empowerment. However, these innovations could worsen existing disparities if not designed intentionally, due to algorithmic bias, unequal digital access, and a lack of culturally responsive models. This paper examines digital dermatology's potential to promote equitable care by focusing on three critical areas: broadening access via digital platforms, ensuring AI fairness through comprehensive datasets, and combating dermatological misinformation using expert-led, AI-powered communication strategies, including a conceptual chatbot that synthesizes and prioritizes dermatologic science for practical use. Drawing on global case studies and insights from the WHO’s AI skin health app and the Skin and Digital Summit, we underscore both the transformative potential and ethical complexities of deploying digital solutions. We advocate for a Radical Dermatology framework that integrates technological advances with community-centered care, equitable data practices, and collaborative design. This vision calls for dermatologists to take the lead, combining scientific rigor with digital innovation to cultivate a more inclusive, intelligent, and trustworthy skin health ecosystem.